45 - Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/0c/e4/6b/0ce46b91-3d22-279b-52fe-d3b1a2a47107/mza_11625791986367831883.jpg/600x600bb.jpg

TMO EPM / Hemato H9J

64 episodes

4 days ago

Podcast de discussão de assuntos em Hematologia do Transplante de Medula Óssea da Escola Paulista de Medicina (UNIFESP) e da Hematologia do Hospital 9 de Julho - DASA

Medicine

Health & Fitness

RSS

All content for TMO EPM / Hemato H9J is the property of TMO EPM / Hemato H9J and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Podcast de discussão de assuntos em Hematologia do Transplante de Medula Óssea da Escola Paulista de Medicina (UNIFESP) e da Hematologia do Hospital 9 de Julho - DASA

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/38086306/38086306-1735233764614-854bc34fe6737.jpg

45 - Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

TMO EPM / Hemato H9J

30 minutes 37 seconds

10 months ago

45 - Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Discussão do artigo: "Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma" de Facon T NEJM 2024

Apresentado por: Dra. Marcella Markman

Discussão por: Dr. Lucas Salviano, Dr. Breno Aires, Dr. Matheus Puls, Dr. Pedro Arruda e Dr. Vinicius Molla